Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments? (Q79633839)
Jump to navigation
Jump to search
scientific article published on 23 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments? |
scientific article published on 23 January 2007 |
Statements
Can tamoxifen therapy be optimized for patients with breast cancer on the basis of CYP2D6 activity assessments? (English)
Chris H Takimoto
23 January 2007